Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O A Ross

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
European Journal of Neurology|August 14, 2009
Calbindin-1 association and Parkinson's diseaseA I Soto-Ortolaza, B Behrouz, C Wider, et al.
European Journal of Neurology|July 14, 2011
Death-associated protein kinase 1 variation and Parkinson's diseaseJ C Dachsel, C Wider, C Vilariño-Güell, et al.
Neuroscience|July 6, 2007
A comparative analysis of leucine-rich repeat kinase 2 (Lrrk2) expression in mouse brain and Lewy body diseaseH L Melrose, C B Kent, J P Taylor, et al.
Neurology|June 10, 2009
Characterization of DCTN1 genetic variability in neurodegenerationC Vilariño-Güell, C Wider, A I Soto-Ortolaza, et al.
Neurology|March 14, 2008
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson diseaseK Haugarvoll, R Rademakers, J M Kachergus, et al.
European Journal of Neurology|August 18, 2015
DNAJC13 p.Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patientsO Lorenzo-Betancor, K Ogaki, A I Soto-Ortolaza, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
European Journal of Neurology|August 14, 2009
Calbindin-1 association and Parkinson's diseaseA I Soto-Ortolaza, B Behrouz, C Wider, et al.
European Journal of Neurology|July 14, 2011
Death-associated protein kinase 1 variation and Parkinson's diseaseJ C Dachsel, C Wider, C Vilariño-Güell, et al.
Neuroscience|July 6, 2007
A comparative analysis of leucine-rich repeat kinase 2 (Lrrk2) expression in mouse brain and Lewy body diseaseH L Melrose, C B Kent, J P Taylor, et al.
Neurology|June 10, 2009
Characterization of DCTN1 genetic variability in neurodegenerationC Vilariño-Güell, C Wider, A I Soto-Ortolaza, et al.
Neurology|March 14, 2008
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson diseaseK Haugarvoll, R Rademakers, J M Kachergus, et al.
European Journal of Neurology|August 18, 2015
DNAJC13 p.Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patientsO Lorenzo-Betancor, K Ogaki, A I Soto-Ortolaza, et al.
Pageof 4